Phase Holographic Imaging expands into Australia and respiratory research
In April Phase Holographic Imaging (PHI) had outstanding orders of approximately 2 MSEK, consisting of 13 HoloMonitor M4 units and 15 orders for the recently launched motorized stage. A portion of these units have now been delivered. Among others, a HoloMonitor M4 with motorized stage has been delivered to one of the leading institutes for respiratory research in Australia – the Woolcock Institute of Medical Research.
To improve the understanding of the mechanisms behind asthma the Respiratory Cellular and Molecular Biology Group will measure volume changes in respiratory muscle cells using PHI’s HoloMonitor technology. The ability to effortlessly measure changes in cell volume is one of the unique and innovative advantages of HoloMonitor technology.
“We see a limited value in reporting individual orders and deliveries that lack strategic value to our investors. However, this installation is of strategic value as it is our first instrument on the Australian continent. Additionally, the order opens up a new market for us – respiratory research”, says Peter Egelberg, CEO of PHI.
Links
- Woolcock Institute of Medical Research – woolcock.org.au
- HoloMonitor M4 motorized stage – www.phiab.se/products/holomonitor-m4#stage
For additional information, please contact:
Peter Egelberg, CEO
Tel: +46 703 19 42 74
E-mail: peter.egelberg@phiab.se
Web: www.phiab.se
Phase Holographic Imaging (PHI) leads the ground-breaking development of time-lapse cytometry instrumentation and software. With the first instrument introduced in 2011, the company today offers a range of products for long-term quantitative analysis of living cell dynamics that circumvent the drawbacks of traditional methods requiring toxic stains. Headquartered in Lund, Sweden, PHI trades through a network of international distributors. Committed to promoting the science and practice of time-lapse cytometry, PHI is actively expanding its customer base and scientific collaborations in cancer research, inflammatory and autoimmune diseases, stem cell biology, gene therapy, regenerative medicine and toxicological studies.
Tags: